Novonesis biosolutions for human health – advancing well-being through science-driven innovation
Home
Amyris and DSM close US$50M...

Amyris and DSM close US$50M strategic transaction on farnesene supply

The deal licenses DSM rights to assume the supply of farnesene to Givaudan

23 Dec 2020
-
Aa
+
NutritionInsight Global EMEA
trans